Literature DB >> 21213593

A model of Helicobacter pylori persistence in a case of gastric cancer.

Rossella Grande1, Mara Di Giulio, Emanuela Di Campli, Soraya Di Bartolomeo, Luigina Cellini.   

Abstract

The aim of this work was to analyze several clones of Helicobacter pylori isolated from a patient with gastric cancer, to evaluate i) genetic variability ii) virulence factors profile and iii) antimicrobial susceptibility against the drugs commonly used in the H. pylori therapy. A total of 32 H. pylori clones isolated from a biopsy sample coming from a patient with gastric cancer previously treated for H. pylori infection, were analyzed for: the genetic variability by amplified fragment polymorphism analysis; the vacA, cagA virulence status by PCR; the antimicrobial susceptibility by minimum inhibitory concentrations with the agar dilution method towards amoxicillin, clarithromycin, levofloxacin and tinidazole. The patient showed a mixed infection with the presence of at least 3 different strains. The clones isolated possessed the vacA, cagA virulence factors with a different allelic combination (vacA s1/i1/m1; s1/i1i2/m1; s2/i2/m2; s2/i1i2/m2) together with repeated cagA EPIYA motif pattern P1P2P3P3P3. Moreover, a pattern of multi-drug resistance was disclosed in the different clones. The presence of multiple H. pylori strains colonizing the same patient, with the main virulence factors displaying a different allelic combination and a different multi-drug resistance among isolates, point out the role of genetic variability generating, in time, more virulent and adapted strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21213593

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  4 in total

1.  Characterization of Key Helicobacter pylori Regulators Identifies a Role for ArsRS in Biofilm Formation.

Authors:  Stephanie L Servetas; Beth M Carpenter; Kathryn P Haley; Jeremy J Gilbreath; Jennifer A Gaddy; D Scott Merrell
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

2.  Heterogeneity of Helicobacter pylori Strains Isolated from Patients with Gastric Disorders in Guiyang, China.

Authors:  Mengheng Mi; Fangcao Wu; Jian Zhu; Fang Liu; Guzhen Cui; Xueqing Wen; Yue Hu; Zhaohui Deng; Xiaojuan Wu; Zhengrong Zhang; Tingna Qi; Zhenghong Chen
Journal:  Infect Drug Resist       Date:  2021-02-11       Impact factor: 4.003

3.  Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA).

Authors:  Rossella Grande; Maria C Di Marcantonio; Iole Robuffo; Arianna Pompilio; Christian Celia; Luisa Di Marzio; Donatella Paolino; Marilina Codagnone; Raffaella Muraro; Paul Stoodley; Luanne Hall-Stoodley; Gabriella Mincione
Journal:  Front Microbiol       Date:  2015-12-16       Impact factor: 5.640

4.  Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.

Authors:  Antonio Francesco Ciccaglione; Mara Di Giulio; Silvia Di Lodovico; Emanuela Di Campli; Luigina Cellini; Leonardo Marzio
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.